{"schema_version":"secwatch.filing_event.v1","accession":"0000096943-26-000087","form_type":"8-K/A","ticker":"TFX","cik":"0000096943","company_name":"TELEFLEX INC","filed_at":"2026-08-05T20:44:06+00:00","discovered_at":"2026-08-05T20:45:01.314157+00:00","generated_at":"2026-08-05T20:45:17.721840+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Teleflex completes $1.5B sale of OEM business; pro forma shows debt reduction and improved income","bullets":["Net cash proceeds of $1.5B ($1.2B after-tax) from OEM business divestiture closed Aug 3, 2026.","$700M of proceeds used to repay term A-2 loan facility; pro forma long-term debt reduced to $1.81B.","Pro forma Q1 2026 income from continuing ops of $1.9M vs reported loss of $4.8M; FY2025 pro forma income $86.9M vs $58.5M.","Ancillary agreements with buyers (Montagu/Kohlberg) for transition services up to 24 months.","Sale of Acute Care and Interventional Urology businesses remains pending."],"urls":{"canonical":"https://secwatch.observer/filing/0000096943-26-000087","json":"https://secwatch.observer/filing/0000096943-26-000087.json","markdown":"https://secwatch.observer/filing/0000096943-26-000087.md","text":"https://secwatch.observer/filing/0000096943-26-000087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/96943/000009694326000087/0000096943-26-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/96943/000009694326000087/tfx-20260803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-05T20:45:17.721840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}